日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An In Vivo Study on the Feasibility of Catheter-Assisted Pulsed Focused Ultrasound Ablation of Atherosclerotic Plaques

导管辅助脉冲聚焦超声消融治疗动脉粥样硬化斑块可行性的体内研究

Samaddar, Abhirup; Adhikari, Prakash; Wang, Dalin; Wu, Sa; Wang, Jinxi; Forrest, Marcus Laird; Yang, Xinmai

Rational Drug Design of Targeted and Enzyme-Cleavable Vitamin E Analogs as a Neoadjuvant to Chemotherapy: In Vitro and In Vivo Evaluation on Reduction of the Cardiotoxicity Side Effect of Doxorubicin

靶向和酶切维生素 E 类似物的合理药物设计作为化疗的新辅助治疗:体外和体内评估其对减少阿霉素心脏毒性副作用的作用

Raghu S Pandurangi, Orsolya Cseh, Hema Artee Luchman, Cynthia Xiuguang Ma, Sanjeewa N Senadheera, Marcus Laird Forrest

Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent

采用载体介导免疫原性细胞死亡诱导的铂类(IV)药物进行瘤内癌症化疗

Groer, Chad; Zhang, Ti; Lu, Ruolin; Cai, Shuang; Mull, Derek; Huang, Aric; Forrest, Melanie; Berkland, Cory; Aires, Daniel; Forrest, Marcus Laird

Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer

Alternol 通过干扰前列腺癌中的克雷布斯循环来消除过量的 ATP 生成。

Li, Changlin; He, Chenchen; Xu, Ying; Xu, Haixia; Tang, Yuzhe; Chavan, Hemantkumar; Duan, Shaofeng; Artigues, Antonio; Forrest, Marcus Laird; Krishnamurthy, Partha; Han, Suxia; Holzbeierlein, Jeffrey M; Li, Benyi

DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways

DOX-Vit D 是一种新型阿霉素给药方法,可通过诱导细胞凋亡同时抑制 Akt 和 mTOR 信号通路来抑制人类骨肉瘤细胞增殖

Zaid H Maayah, Ti Zhang, Marcus Laird Forrest, Samaa Alrushaid, Michael R Doschak, Neal M Davies, Ayman O S El-Kadi

Injectable Chemotherapy Downstaged Oral Squamous Cell Carcinoma from Nonresectable to Resectable in a Rescue Dog: Diagnosis, Treatment, and Outcome

注射化疗使一只救援犬的口腔鳞状细胞癌从不可切除变为可切除:诊断、治疗和结果

Cai, Shuang; Zhang, Ti; Groer, Chad; Forrest, Melanie; Aires, Daniel; Otte, Vern; Barchman, Sally; Faerber, Abby; Forrest, Marcus Laird

Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat

利达福罗莫司DSPE-PEG2000胶束制剂在大鼠体内的药代动力学评价

Remsberg, Connie M; Zhao, Yunqi; Takemoto, Jody K; Bertram, Rebecca M; Davies, Neal M; Forrest, Marcus Laird